Diametric Capital’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $770K | Buy |
59,195
+46,569
| +369% | +$606K | 0.41% | 67 |
|
|
2025
Q1 | $134K | Buy |
+12,626
| New | +$134K | 0.16% | 152 |
|
|
2024
Q4 | – | Sell |
-34,102
| Closed | -$792K | – | 318 |
|
|
2024
Q3 | $792K | Buy |
34,102
+1,337
| +4% | +$31K | 0.39% | 71 |
|
|
2024
Q2 | $798K | Buy |
32,765
+19,766
| +152% | +$481K | 0.43% | 60 |
|
|
2024
Q1 | $439K | Sell |
12,999
-13,919
| -52% | -$470K | 0.24% | 97 |
|
|
2023
Q4 | $849K | Buy |
26,918
+788
| +3% | +$24.8K | 0.52% | 56 |
|
|
2023
Q3 | $668K | Buy |
26,130
+4,856
| +23% | +$124K | 0.28% | 112 |
|
|
2023
Q2 | $610K | Sell |
21,274
-10,895
| -34% | -$312K | 0.27% | 100 |
|
|
2023
Q1 | $771K | Buy |
+32,169
| New | +$771K | 0.37% | 82 |
|
|
2022
Q3 | – | Sell |
-22,499
| Closed | -$354K | – | 258 |
|
|
2022
Q2 | $354K | Buy |
+22,499
| New | +$354K | 0.26% | 136 |
|
|
2021
Q4 | – | Sell |
-5,280
| Closed | -$252K | – | 159 |
|
|
2021
Q3 | $252K | Sell |
5,280
-1,137
| -18% | -$54.3K | 0.2% | 108 |
|
|
2021
Q2 | $217K | Buy |
+6,417
| New | +$217K | 0.16% | 111 |
|
|
2020
Q4 | – | Sell |
-10,248
| Closed | -$440K | – | 164 |
|
|
2020
Q3 | $440K | Sell |
10,248
-1,230
| -11% | -$52.8K | 0.33% | 74 |
|
|
2020
Q2 | $536K | Sell |
11,478
-39,543
| -78% | -$1.85M | 0.41% | 72 |
|
|
2020
Q1 | $693K | Sell |
51,021
-961
| -2% | -$13.1K | 0.84% | 47 |
|
|
2019
Q4 | $565K | Buy |
51,982
+13,521
| +35% | +$147K | 0.41% | 79 |
|
|
2019
Q3 | $395K | Buy |
38,461
+254
| +0.7% | +$2.61K | 0.33% | 76 |
|
|
2019
Q2 | $361K | Sell |
38,207
-16,979
| -31% | -$160K | 0.23% | 82 |
|
|
2019
Q1 | $377K | Buy |
+55,186
| New | +$377K | 0.3% | 75 |
|